Skip to content

Firm News

Sichenzia Ross Ference Carmel LLP Represents Healthcare Triangle in $4.235 Million Private Placement

June 16, 2026

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $2.5 Million Best-Efforts Offering of CEL-SCI Corporation

June 16, 2026

Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in Acquisition of NOMAD Transportable Power Systems

June 12, 2026

Sichenzia Ross Ference Carmel LLP Represents Ocean Capital Acquisition Corporation in $115 Million Initial Public Offering

June 12, 2026

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $150 Million Initial Public Offering of JAB Acquisition Corp I

June 10, 2026

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $5.4 Million Registered Direct Offering of Core AI Holdings, Inc.

June 10, 2026

Sichenzia Ross Ference Carmel LLP Represents LIXTE Biotechnology in $16.6 Million Registered Direct Offering

June 8, 2026

Sichenzia Ross Ference Carmel LLP Represents BriaCell Therapeutics Corp. in $4.7 Million Best-Efforts Offering

June 1, 2026

Sichenzia Ross Ference Carmel LLP Represents NextNRG, Inc. in $6.4 Million Private Placement Offering

June 1, 2026

Sichenzia Ross Ference Carmel LLP Represents Fincadia Advisors in $70.13 Million Series Investing in Shield AI

May 27, 2026

Sichenzia Ross Ference Carmel LLP Represents Fincadia Advisors in $10.85 Million Series Investing in Erebor

May 27, 2026

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $2.42 Million Series Investing in OpenAI

May 22, 2026

Sichenzia Ross Ference Carmel LLP Represents Ladenburg Thalmann & Co. Inc. in $10 Million Public Offering of QT Imaging Holdings

May 22, 2026

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $2 Million Registered Direct Offering of Jupiter Neurosciences

May 22, 2026

Sichenzia Ross Ference Carmel LLP Represents Sunshine Biopharma Inc. in Up to $18 Million Public Offering

May 20, 2026

Sichenzia Ross Ference Carmel LLP Sponsors “Secondary is Primary” Panel Discussion Event at New York Tech Week 2026

May 19, 2026

Sichenzia Ross Ference Carmel LLP Represents E.F. Hutton in $5 Million Public Offering of XORTX Therapeutics

May 18, 2026

Sichenzia Ross Ference Carmel LLP Represents D. Boral Capital in $2 Million Registered Direct Offering of NanoViricides

May 18, 2026

Sichenzia Ross Ference Carmel LLP Represents ThinkEquity in $7.2 Million Public Offering of CEL-SCI Corporation

May 15, 2026

Sichenzia Ross Ference Carmel LLP Represents American Ventures IM and Dominari Securities in $7.26 Million Series Investing in Genius Group Limited

May 13, 2026

Sichenzia Ross Ference Carmel LLP Represents iSpecimen Inc. in $2.5 Million Private Placement

May 12, 2026